Alcon Inc
ALC: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$97.00 | Bcpvhjg | Jhqzrrr |
Alcon's Innovation Sparks Further Market Penetration and Potential Long-Term Growth
Business Strategy and Outlook
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical.